Aegirbio Signs Agreement with Salofa for the Veterinary Market and Receives A First Order Worth Approximately SEK 2 Million

Aegirbio has signed a non-exclusive agreement with the Finnish company Salofa Oy. The agreement is for veterinary applications and gives Salofa access to AegirBio's instruments and MagnetoImmunoAssay (MIA) for its own development of tests in veterinary medicine. With this agreement, AegirBio will, via its subsidiary Magnasense Technologies OY, sell its existing MagniaReader to Salofa, which will bring it to market with proprietary tests for horses, dogs and cats.

Magnasense receives revenue from the sale of instruments and royalties on the disposable products ie. tests that Salofa sells for the instruments. When the contract was signed, an order was added to the value of EUR 195,000 (approx.

SEK 2 million) for year one.